Zhangjiang Science & Technology Investment Corporation
VC Fund
Zhangjiang, China
Zhangjiang Science & Technology Investment Corporation is a VC fund in Zhangjiang focused on Medical and Health Care. Shanghai Zhangjiang Science & Technology Investment Corporation (ZJ STIC) was founded in 2005. The Company is the investment strategy arm of Zhangjiang High-tech Park.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 28%
Last updated:
For AI agents: llms.txt
Industries Zhangjiang Science & Technology Investment Corporation invests in
Stages Zhangjiang Science & Technology Investment Corporation invests in
Countries Zhangjiang Science & Technology Investment Corporation invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Sun Weiqin
|
|||
Investment Focus
Industry
- Medical 5 (16%)
- Health Care 5 (16%)
- Manufacturing 5 (16%)
- Software 4 (13%)
- Biopharma 4 (13%)
Stage
- Series A 13 (41%)
- Angel 9 (28%)
- Series B 6 (19%)
- Seed 2 (6%)
- Series E 1 (3%)
Country
- China 29 (91%)
- Switzerland 1 (3%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Sun Weiqin
General Manager
|
General Manager | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Zheyuan Technology is an AI pharmaceutical R&D solution provider. | $29.6M / Series A / Aug 05, 2026 | |
|
|
TranscEngram is an AI research and technology company focused on advancing artificial intelligence. | Angel / Jul 05, 2026 | |
|
|
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment. | $58.8M / Series B / May 18, 2026 | |
|
|
Jinnao Medical is a high-tech enterprise specializing in the research and development of invasive brain-computer interface (BCI) technology, focusing on the design, engineering, and commercialization of advanced neural interface systems that enable direct communication between the human brain and external devices, with applications spanningneurological disorder treatment, rehabilitation, and next-generation human–machine interaction. | Angel / Apr 27, 2026 | |
|
|
Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security. | Venture - Series Unknown / Jul 07, 2025 | |
|
|
Kepler Robotics is a high-tech innovative enterprise focusing on the research and development, production and application ecology of general humanoid robots. | Seed / Apr 24, 2025 | |
|
|
Fourier Intelligence is a Shanghai-based technology and design company providing exoskeleton robotic product and service on rehabilitation & orthoses. Its products include upper-limb rehab robotics and lower-limb exoskeleton robot, which can help the disabled go beyond of the physical limits, stand up and walk again. Its exoskeleton productscan also decrease fatigue and increase productivity whilst unloading supplies or enabling workers/soldiers to carry heavy objects. | Series E / Jan 07, 2025 | |
|
|
NK CellTech is a biotechnology company that specializes in the development of innovative technologies for the treatment of NK cell therapy. | Series A / Nov 22, 2024 | |
|
|
Di-Matrix is an IT firm that offers cloud based enterprise software solutions. | $13.8M / Series B / Nov 15, 2023 | |
|
|
Open Source China is a software open source technology community. The community has formed several major channel contents such as open source software libraries, code sharing, information, collaborative translation, discussion forums, and blogs. Users can discover, use, and exchange open source technologies through the community. It also providestechnical questions and answers, software information and other services. | $107.1M / Series B / Jun 26, 2023 | |
| See all 32 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Zhangjiang Science & Technology Investment Corporation invest in?
Zhangjiang Science & Technology Investment Corporation invests primarily in Medical, Health Care and Manufacturing startups, most often at Series A and Angel stage. Most of the 32 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Zhangjiang Science & Technology Investment Corporation?
Public channels for Zhangjiang Science & Technology Investment Corporation include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Zhangjiang Science & Technology Investment Corporation?
The team at Zhangjiang Science & Technology Investment Corporation includes Sun Weiqin (General Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!